Verition Fund Management

Verition Fund Management’s Procept Biorobotics PRCT Stock Holding History

Verition Fund Management’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-34,800	Closed	-$1.09M	–	3281
2025 Q4	$1.09M	Sell	34,800 -26,993	-44%	-$895K	0.01%	2086
2025 Q3	$2.21M	Buy	61,793 +26,815	+77%	+$1.22M	0.01%	1888
2025 Q2	$2.01M	Sell	34,978 -10,656	-23%	-$602K	0.01%	1933
2025 Q1	$2.66M	Sell	45,634 -9,644	-17%	-$658K	0.02%	1377
2024 Q4	$4.45M	Buy	55,278 +28,668	+108%	+$2.45M	0.02%	970
2024 Q3	$2.13M	Buy	+26,610	New	+$1.89M	0.01%	1375
2024 Q2	–	Sell	-22,837	Closed	-$1.13M	–	3218
2024 Q1	$1.13M	Buy	22,837 +16,600	+266%	+$790K	0.01%	1544
2023 Q4	$261K	Buy	+6,237	New	+$212K	﹤0.01%	1871

Other funds holding PRCT

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BNP Paribas Asset Management

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Mackenzie Financial

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return